News

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BlackLine Inc (Symbol: BL), where a total of 6,713 contracts have traded so far, representing approximately 671,300 underlying shares. That amounts to about 66% of BL's average daily trading volume over the past month of 1.0 million shares. Especially high volume was seen for the $65 strike put option expiring March 15, 2024, with 3,233 contracts trading so far today, representing approximately 323,300 underlying shares of BL. Below is a chart showing BL's trailing twelve month trading history, with the $65 strike highlighted in orange:

Blackrock Inc (Symbol: BLK) saw options trading volume of 3,464 contracts, representing approximately 346,400 underlying shares or approximately 65.7% of BLK's average daily trading volume over the past month, of 527,600 shares. Particularly high volume was seen for the $860 strike call option expiring March 15, 2024, with 1,126 contracts trading so far today, representing approximately 112,600 underlying shares of BLK. Below is a chart showing BLK's trailing twelve month trading history, with the $860 strike highlighted in orange:

And Surgery Partners Inc (Symbol: SGRY) options are showing a volume of 6,930 contracts thus far today. That number of contracts represents approximately 693,000 underlying shares, working out to a sizeable 65.6% of SGRY's average daily trading volume over the past month, of 1.1 million shares. Especially high volume was seen for the $25 strike put option expiring January 17, 2025, with 4,600 contracts trading so far today, representing approximately 460,000 underlying shares of SGRY. Below is a chart showing SGRY's trailing twelve month trading history, with the $25 strike highlighted in orange:

For the various different available expirations for BL options, BLK options, or SGRY options, visit StockOptionsChannel.com.

HOV Insider Buying
GEF Average Annual Return
RCPT Historical Stock Prices

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.